Clinical Trial Update: Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ARO-RAGE in healthy subjects and patients with asthma indicates the Phase 1/2 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ARO-RAGE (RAGE antagonist (inhaled))

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED